VINC Vincerx Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VINC

Price (delayed)

$0.8771

Market cap

$18.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.89

Enterprise value

$8.43M

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs ...

Highlights
VINC's EPS is up by 37% year-on-year and by 14% since the previous quarter
The company's net income rose by 36% YoY and by 14% QoQ
The company's equity has shrunk by 76% YoY and by 29% QoQ
The quick ratio has dropped by 58% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://vincerx.com
Peers: NWBO

Key stats

What are the main financial stats of VINC
Market
Shares outstanding
21.41M
Market cap
$18.78M
Enterprise value
$8.43M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$40.16M
EBITDA
-$39.24M
Free cash flow
-$40.45M
Per share
EPS
-$1.89
Free cash flow per share
-$1.9
Book value per share
$0.52
Revenue per share
$0
TBVPS
$0.86
Balance sheet
Total assets
$18.22M
Total liabilities
$7M
Debt
$2.5M
Equity
$11.22M
Working capital
$9.13M
Liquidity
Debt to equity
0.22
Current ratio
2.63
Quick ratio
2.48
Net debt/EBITDA
0.26
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-126.3%
Return on equity
-187.7%
Return on invested capital
-246.5%
Return on capital employed
-318.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VINC stock price

How has the Vincerx Pharma stock price performed over time
Intraday
-5.69%
1 week
20.15%
1 month
-86.71%
1 year
-44.49%
YTD
-25.67%
QTD
-82.67%

Financial performance

How have Vincerx Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$42.61M
Net income
-$40.16M
Gross margin
N/A
Net margin
N/A
VINC's operating income is up by 40% year-on-year and by 15% since the previous quarter
The company's net income rose by 36% YoY and by 14% QoQ

Growth

What is Vincerx Pharma's growth rate over time

Valuation

What is Vincerx Pharma stock price valuation
P/E
N/A
P/B
1.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VINC's EPS is up by 37% year-on-year and by 14% since the previous quarter
The company's equity has shrunk by 76% YoY and by 29% QoQ
The stock's P/B is 67% below its 5-year quarterly average of 5.1 but 19% above its last 4 quarters average of 1.4

Efficiency

How efficient is Vincerx Pharma business performance
VINC's return on equity has dropped by 102% year-on-year and by 23% since the previous quarter
The ROA has plunged by 62% YoY and by 14% from the previous quarter
Vincerx Pharma's return on invested capital has increased by 39% YoY but it has decreased by 39% QoQ

Dividends

What is VINC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VINC.

Financial health

How did Vincerx Pharma financials performed over time
The total assets is 160% more than the total liabilities
The total assets has plunged by 69% YoY and by 31% from the previous quarter
The quick ratio has dropped by 58% year-on-year
The debt is 78% less than the equity
The company's equity has shrunk by 76% YoY and by 29% QoQ
The debt has contracted by 27% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.